Rapid detection of the hepatitis B virus YMDD mutant using TaqMan-minor groove binder probes

Clinica Chimica Acta

Volumn 395, Issue 1-2, 2008, Pages 151-154

  Hua, Rui ^a   Tanaka, Yasuo ^a   Fukai, Kenichi ^b   Tada, Motohisa ^a   Seto, Motoko ^a   Asaoka, Yoshinari ^a   Ohta, Miki ^a   Goto, Tadashi ^a   Kanai, Fumihiko ^a   Kato, Naoya ^a   Yoshida, Haruhiko ^a   Kawabe, Takao ^a   Yokosuka, Osamu ^b   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Hepatitis B virus; Minor groove binder probe; TaqMan PCR; YMDD mutant

Indexed keywords

LAMIVUDINE; VIRUS DNA;

ARTICLE; BLOOD SAMPLING; CASE REPORT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DILUTION; DNA HYBRIDIZATION; GENE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MOLECULAR CLONING; MOLECULAR PROBE; PLASMID; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TAQMAN MINOR GROOVE BINDER PROBE; VIRUS DETECTION; VIRUS STRAIN; WILD TYPE;

AMINO ACID MOTIFS; DNA MUTATIONAL ANALYSIS; DNA PROBES; DNA, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TAQ POLYMERASE;

HEPATITIS B VIRUS;

EID: 47649107688     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.06.013     Document Type: Article

References (13)

1. Lee W.M. Hepatitis B virus infection. N. Engl. J. Med. 337 (1997) 1733-1745
2. Chayama K., Suzuki Y., Kobayashi M., Tsubota A., Hashimoto M., Miyano Y., et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 27 (1998) 1711-1716
3. Allen M.I., Gauthier J., DesLauriers M., Bourne E.J., Carrick K.M., Baldanti F., et al. Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine. J. Clin. Microbiol. 37 (1999) 3338-3347
4. Cane P.A., Mutimer D., Ratcliffe D., Cook P., Beards G., Elias E., et al. Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation. Antivir. Ther. 4 (1999) 7-14
5. Stuyver L., Van Geyt C., De Gendt S., Van Reybroeck G., Zoulim F., Leroux-Roels G., et al. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J. Clin. Microbiol. 38 (2000) 702-707
6. Kirishima T., Okanoue T., Daimon Y., Itoh Y., Nakamura H., Morita A., et al. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J. Hepatol. 37 (2002) 259-265
7. Shi M., Yang Z.J., Wang R.S., Zhang H., Zhu Y.F., Xu Y.P., et al. Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection. Clin. Chim. Acta. 373 (2006) 172-175
8. Malmstrom S., Hannoun C., and Lindh M. Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR. J. Virol. Methods 143 (2007) 147-152
9. Afonina I.A., Reed M.W., Lusby E., Shishkina I.G., and Belousov Y.S. Minor groove binder-conjugated DNA probes for quantitative DNA detection by hybridization-triggered fluorescence. Biotechniques 32 (2002) 940-944
10. Ono-Nita S.K., Kato N., Shiratori Y., Masaki T., Lan K.H., Carrilho F.J., et al. YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: a study by in vitro full-length viral DNA transfection. Hepatology 29 (1999) 939-945
11. Tanaka Y., Kanai F., Tada M., Asaoka Y., Guleng B., Jazag A., et al. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients. Oncogene 25 (2006) 2950-2952
12. Hussain M., Fung S., Libbrecht E., Sablon E., Cursaro C., Andreone P., et al. Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir. J. Clin. Microbiol. 44 (2006) 1094-1097
13. Cane P.A., Cook P., Ratcliffe D., Mutimer D., and Pillay D. Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus. Antimicrob. Agents Chemother. 43 (1999) 1600-1608